ACB · Aurora Cannabis Inc
Market Cap
$256.09M
Shares
63.31M
Volume · Oct 5
4.63M
Avg daily vol (3M)
1.35M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.46
Open$4.37
Day$4.30–4.65
52W close$2.58–6.17
Avg vol 30d1.1M
Short int7.4M · 11.8% float · 8.5d
Short vol43%
Last earningsAug 5, 2026
DataJan 2020–Oct 2026
Up next
Next earnings call
Nov 23, 2026
Est · unconfirmed
· in 7 wks
call held Sep 30, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-31.0%
Trailing year
Short interest
11.8%
Latest settlement · 8.5 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
+25%
above
Price vs 50-day avg
+21%
above
RSI (14)
71
overbought
MACD trend
Negative
52-week position
52%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+13%
trailing
6-month return
+26%
trailing
YTD return
+6%
this year
Relative strength
+15%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Distributing
2 of 153 funds reported for Sep 30 · net -500 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
11.76% of float · ▲ +1.8% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
153 holders — near 3-yr low, contrarian setup
Squeeze score
87
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
59%
annualized · 1-yr
Max drawdown
−58%
past year
ATR
4.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Dec 31, 2021
by the first half of fiscal 2023
Annualized cost savings
$150M – $170M
annualized basis
Cost savings
$150M – $170M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
+25%
Bullish
Price vs 50-day avg
+21%
Bullish
RSI (14)
71
Bearish
MACD trend
Negative
Bearish
52-week position
52%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
Golden cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow
Distributing
2 of 153 funds reported for Sep 30 · net -500 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
11.76% of float · ▲ +1.8% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
153 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $3
Now $4 · 52%
Range high $6
vs 200-day avg +25%
vs 50-day avg +21%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ACB
this stock
Aurora Cannabis Inc
|
$256.09M | +5.7% | — | — | 11.8% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$60.23B | +14.2% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$46.00B | -6.1% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$45.67B | +27.1% | +4.3% | 64.3 | 2.7% |
|
HLN
Haleon plc
|
$40.72B | -12.8% | — | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ACB | +9.1% | +12.9% | +26.4% | +14.4% | +5.7% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | +7.9% | +12.3% | +14.8% | +12.8% | -7.9% |